FIRST WAVE BIOPHARMA (FWBI) Forecast, Price Target & Analyst Ratings

NASDAQ:FWBI • US33749P4081

Current stock price

2.96 USD
+0.13 (+4.59%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FIRST WAVE BIOPHARMA (FWBI).

Forecast Snapshot

Consensus Price Target

Price Target
$36.72
+ 1,140.54% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 14, 2024
Period
Q1 / 2024
EPS Estimate
-$2.48
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$36.72
Upside
+ 1,140.54%
From current price of $2.96 to mean target of $36.72, Based on 8 analyst forecasts
Low
$36.36
Median
$36.72
High
$37.80

Price Target Revisions

1 Month
0.00%
3 Months
-10.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for FWBI. The average price target is 36.72 USD. This implies a price increase of 1140.54% is expected in the next year compared to the current price of 2.96.
The average price target has been revised downward by 10% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FWBI Current Analyst RatingFWBI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

FWBI Historical Analyst RatingsFWBI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
FWBI was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FWBI.
In the previous month the buy percentage consensus was at a similar level.
FWBI was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-03-25HC Wainwright & Co.Reiterate Neutral
2024-03-15Roth MKMMaintains Buy -> Buy
2024-01-03Roth MKMMaintains Buy -> Buy
2023-09-19Roth MKMReiterate Buy -> Buy
2023-07-14HC Wainwright & Co.Downgrade Buy -> Neutral
2023-06-29HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-13HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-04-26HC Wainwright & Co.Reiterate Buy
2023-04-05HC Wainwright & Co.Maintains Buy
2023-03-09HC Wainwright & Co.Reiterate Buy
2023-02-03HC Wainwright & Co.Reiterate Buy
2023-01-31HC Wainwright & Co.Reiterate Buy
2023-01-26HC Wainwright & Co.Reiterate Buy
2022-12-02HC Wainwright & Co.Maintains Buy
2022-05-26Roth CapitalMaintains Buy
2021-12-07Maxim GroupDowngrade Buy -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 14, 2024
Period
Q1 / 2024
EPS Estimate
-$2.48
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
93.19%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-0.62%
EPS (3 Months)
-6.81%

Next Earnings Summary

FWBI is expected to report earnings on 8/14/2024. The consensus EPS estimate for the next earnings is -2.48 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
FWBI revenue by date.FWBI revenue by date.
N/AN/AN/AN/AN/AN/A
178.96%		N/A
90.20%
EBITDA
YoY % growth
FWBI ebitda by date.FWBI ebitda by date.
-4M-5.6M
-40.00%		-9.47M
-69.11%		-12.63M
-33.37%		-13.72M
-8.63%		-25.86M
-88.48%		-56.17M
-117.21%		-12.65M
77.48%		-15.742M
-24.44%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
FWBI ebit by date.FWBI ebit by date.
-4.73M-6.33M
-33.83%		-10.22M
-61.45%		-13.43M
-31.41%		-14.74M
-9.75%		-26.43M
-79.31%		-56.71M
-114.57%		-12.68M
77.64%		-15.771M
-24.38%		N/A
-37.50%		N/A
-47.77%		N/A
-67.33%		N/A
-11.46%		N/A
125.27%		N/A
740.32%		N/A
118.36%
Operating Margin
FWBI operating margin by date.FWBI operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
FWBI eps by date.FWBI eps by date.
N/AN/A-315.00
95.01%		-270.00
14.29%		-218.53
19.06%		-255.00
-16.69%		-1,248.15
-389.47%		-362.30
70.97%		-88.75
75.50%		N/A
95.87%		N/A
56.88%		N/A
-45.16%		N/A
3.11%		N/A
121.10%		N/A
628.26%		N/A
50.75%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-2.48
93.19%		-0.33
99.14%		-0.80
91.30%		-0.73
86.37%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-4.218M
-3.88%		-4.858M
-16.23%		-5.738M
-67.27%		-6.871M
-67.84%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FWBI Yearly Revenue VS EstimatesFWBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 100M 200M 300M
FWBI Yearly EPS VS EstimatesFWBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10K -20K -30K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.45%
EPS Next 5 Year
14.93%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FIRST WAVE BIOPHARMA / FWBI Forecast FAQ

What is the average price target for FIRST WAVE BIOPHARMA (FWBI) stock?

8 analysts have analysed FWBI and the average price target is 36.72 USD. This implies a price increase of 1140.54% is expected in the next year compared to the current price of 2.96.

Can you provide the upcoming earnings date for FIRST WAVE BIOPHARMA?

FIRST WAVE BIOPHARMA (FWBI) will report earnings on 2024-08-14, before the market open.

What are the consensus estimates for FIRST WAVE BIOPHARMA (FWBI) next earnings?

The consensus EPS estimate for the next earnings of FIRST WAVE BIOPHARMA (FWBI) is -2.48 USD and the consensus revenue estimate is 0 USD.

How do analysts rate FIRST WAVE BIOPHARMA (FWBI)?

The consensus rating for FIRST WAVE BIOPHARMA (FWBI) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.